Primary Country (Mandatory)

Other Country (Optional)

Set News Language for United States

Primary Language (Mandatory)
Other Language[s] (Optional)
No other language available

Set News Language for World

Primary Language (Mandatory)
Other Language(s) (Optional)

Set News Source for United States

Primary Source (Mandatory)
Other Source[s] (Optional)

Set News Source for World

Primary Source (Mandatory)
Other Source(s) (Optional)
  • Countries
    • India
    • United States
    • Qatar
    • Germany
    • China
    • Canada
    • World
  • Categories
    • National
    • International
    • Business
    • Entertainment
    • Sports
    • Special
    • All Categories
  • Available Languages for United States
    • English
  • All Languages
    • English
    • Hindi
    • Arabic
    • German
    • Chinese
    • French
  • Sources
    • India
      • AajTak
      • NDTV India
      • The Hindu
      • India Today
      • Zee News
      • NDTV
      • BBC
      • The Wire
      • News18
      • News 24
      • The Quint
      • ABP News
      • Zee News
      • News 24
    • United States
      • CNN
      • Fox News
      • Al Jazeera
      • CBSN
      • NY Post
      • Voice of America
      • The New York Times
      • HuffPost
      • ABC News
      • Newsy
    • Qatar
      • Al Jazeera
      • Al Arab
      • The Peninsula
      • Gulf Times
      • Al Sharq
      • Qatar Tribune
      • Al Raya
      • Lusail
    • Germany
      • DW
      • ZDF
      • ProSieben
      • RTL
      • n-tv
      • Die Welt
      • Süddeutsche Zeitung
      • Frankfurter Rundschau
    • China
      • China Daily
      • BBC
      • The New York Times
      • Voice of America
      • Beijing Daily
      • The Epoch Times
      • Ta Kung Pao
      • Xinmin Evening News
    • Canada
      • CBC
      • Radio-Canada
      • CTV
      • TVA Nouvelles
      • Le Journal de Montréal
      • Global News
      • BNN Bloomberg
      • Métro
Vitamin D supplement found to lower risk of melanoma, new study finds

Vitamin D supplement found to lower risk of melanoma, new study finds

CTV
Tuesday, January 10, 2023 12:08:00 PM UTC

New research has found that people who regularly consume vitamin D supplements have a lower risk of skin cancer, as opposed to those who do not take the supplement.

Melanoma is one of the few cancers on the rise in cases in Canada, and now a new study has found one way to potentially lower the risk of getting the life-threatening disease.

New research conducted by dermatologists at the University of Eastern Finland in collaboration with Kuopio University Hospital in Finland found that people who regularly take vitamin D supplementation are at a lower risk for melanoma, as opposed to those who do not take the supplement.

Melanoma is a potentially deadly form of skin cancer and it was estimated 9,000 Canadians were diagnosed with the illness in 2022, according to the Canadian Cancer Society.

While vitamin D is known to be naturally manufactured through the skin by the sun, the National Council on Skin Cancer Prevention, a U.S.-based organization, advises that adults and children should avoid intentional exposure to the harmful UV radiation of sun rays, which are known to cause skin cancers, and instead use diet and supplementation to get adequate levels of the fat-soluble vitamin. 

In the study, dermatologists discovered the power of the supplementation by analyzing the background information and medical history of 498 recruited adults who were at risk for any kind of skin cancer, as well as performed an examination of their skin. 

Based on this, the patients were classified into varying levels of skin cancer risk categories starting at low, moving to moderate risk, and up to high risk.

Examples of skin cancers the patients were at risk for included basal cell carcinoma, squamous cell carcinoma, or melanoma, which is one of the most common cancer types found in young Canadian adults aged 15 to to 49.

Read full story on CTV
Share this story on:-
More Related News
© 2008 - 2025 Webjosh  |  News Archive  |  Privacy Policy  |  Contact Us